Adults 18 to 35, male only, with Stress Disorders, Traumatic or Stress Disorders, Traumatic, Acute. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Housing StabilityPrimary· 4 months post release
Stable housing was defined as living in one's own room, apartment, or house, or with family, with an expected duration of residence of 4 months or more, or tenancy rights. A 10- item measure will assess housing stability.
Group
Value
95% CI
Treatment Group
17
Control Group
65
Treatment Group
7
Control Group
23
Treatment Group
172
Control Group
119
Housing StabilityPrimary· 8 months post release
Stable housing was defined as living in one's own room, apartment, or house, or with family, with an expected duration of residence of 4 months or more, or tenancy rights. A 10- item measure will assess housing stability.
Group
Value
95% CI
Treatment Group
18
Control Group
60
Treatment Group
8
Control Group
29
Treatment Group
170
Control Group
118
Employment StabilityPrimary· 4 months post release
Employment Stability is measure on a continuum, based on the number of jobs held in the last 4 months and number of days worked at each Employment. The employment must be for at least 15 hours a week. A 10-item measure will assess employment stability
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
16
Treatment as Usual (TAU)
67
Comprehensive Trauma-Based Reentry Program
7
Treatment as Usual (TAU)
18
Comprehensive Trauma-Based Reentry Program
173
Treatment as Usual (TAU)
122
Employment StabilityPrimary· 8 months post release
Employment Stability is based on the number of jobs held in the last 4 months and number of days worked at each Employment. The employment must be for at least 15 hours a week. A 10-item measure will assess employment stability
Employed
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
22
Treatment as Usual (TAU)
69
Not Employed
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
4
Treatment as Usual (TAU)
18
Non-Responsive
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
170
Treatment as Usual (TAU)
120
Brief Symptom InventoryPrimary· 4 months post release
Utilizing the Brief Symptom Inventory (BSI) to assess depression and anxiety symptoms in participants. The BSI is a 53-item self-report screening tool that asks respondents to rate their level of psychological distress over the past seven days based on a five-point Likert scale (0 = "not at all" to 5 = "extremely"). The BSI provides subscale scores on dimensions of somatization, depression, and anxiety as well as a Global Severity Index (GSI) that is calculated based on a sum of all items. Subscale scores range from 0 to 4. Higher scores on the BSI indicate higher levels of symptomology.
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
.451
± .804
Treatment as Usual (TAU)
.536
± .813
Brief Symptom InventoryPrimary· 8 months post release
Utilizing the Brief Symptom Inventory (BSI) to assess depression and anxiety symptoms in participants. The BSI is a 53-item self-report screening tool that asks respondents to rate their level of psychological distress over the past seven days based on a five-point Likert scale (0 = "not at all" to 5 = "extremely"). The BSI provides subscale scores on dimensions of somatization, depression, and anxiety as well as a Global Severity Index (GSI) that is calculated based on a sum of all items. Subscale scores range from 0 to 4. Higher scores on the BSI indicate higher levels of symptomology.
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
.618
± .932
Treatment as Usual (TAU)
.553
± .789
Mini International Neuropsychiatric InterviewPrimary· 4 months post release
Utilizing the 9-item substance use disorder subscale of the MINI International Neuropsychiatric Interview (MINI) to assess current incidence of substance use disorders. Items are rated on a dichotomous Yes/No scale and follow psychiatric guidelines of the DSM-5.
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
8
Treatment as Usual (TAU)
22
Comprehensive Trauma-Based Reentry Program
21
Treatment as Usual (TAU)
67
Depressive SymptomsSecondary· 8 months post release
Depressive symptoms marked by dysphoric mood, inactivity, lack of interest, insomnia, feelings of worthlessness, diminished ability to think, and thoughts of suicide. Depressive symptoms will be measured using the Brief Symptom Inventory, a 53-items with a 6 question sub-scale of depressive symptoms were a respondent characterizes the intensity of distress (0 ="not at all" to 4="extremely").The higher score the more depressive symptoms.
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
.730
± .964
Treatment as Usual (TAU)
.440
± .670
Anxiety SymptomsSecondary· 8 months post release
Anxiety symptoms identified as apprehension or fear of impending actual or imagined danger, vulnerability, or uncertainty. Anxiety Symptoms will be measured using the Brief Symptom Inventory is a 53-items with a 6 question sub-scale of anxiety symptoms were a respondent characterizes the intensity of distress (0 ="not at all" to 4="extremely").The higher score the more symptoms of anxiety.
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
.60
± 1.15
Treatment as Usual (TAU)
.574
± .812
Incidence of Substance Use DisorderSecondary· 8 months post release
A pathological pattern of impairment related to the overuse of, or dependence on, psychoactive drugs, prescription medications, or other substances. A 9-item substance use disorder subscale of the MINI assesses current incidence of substance use disorders. Items are rated on a dichotomous Yes/No scale and follow psychiatric guidelines of the DSM-5.
Substance Use Disorder
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
9
Treatment as Usual (TAU)
23
No Substance Use Disorder
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
20
Treatment as Usual (TAU)
67
Coping Self-Efficacy ScaleSecondary· 4 months post release
Utilizing the Coping Self-Efficacy Scale (CSES) to assess coping self-efficacy. The CSES is an 26-item self-report tool that asks respondents to indicate if they feel they can do accomplish 26 specific things if when they are having problems. Responses are based on an 11-point Likert scale (0 = "Cannot do at all" to 10 = "Certain can do"). The CSES provides subscale scores on dimensions of problem-focused coping, stopping unpleasant emotions and thoughts, and social support as well as a total coping self-efficacy score that is calculated based on a sum of all items. Problem focused subscale sc
Using Problem-Focused Coping
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
45.58
± 8.43
Treatment as Usual (TAU)
43.52
± 13.45
Stop Unpleasant emotions and thoughts
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
29.1667
± 5.75339
Treatment as Usual (TAU)
29.4091
± 9.03205
Get Support From Friends and Family
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
20.1250
± 5.47177
Treatment as Usual (TAU)
20.6818
± 7.89812
Coping Self-efficacySecondary· 8 months post release
he CSES is an 26-item self-report tool that asks respondents to indicate if they feel they can do accomplish 26 specific things if when they are having problems. Responses are based on an 11-point Likert scale (0 = "Cannot do at all" to 10 = "Certain can do"). The CSES provides subscale scores on dimensions of problem-focused coping, stopping unpleasant emotions and thoughts, and social support as well as a total coping self-efficacy score that is calculated based on a sum of all items. Problem focused subscale scores range from 0 to 60, emotion-focused subscale scores range from 0 to 40, and
Using Problem-Focused Coping
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
48.23
± 10.03
Treatment as Usual (TAU)
44.93
± 10.16
Stop Unpleasant Emotions and Thoughts
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
30.3462
± 8.01470
Treatment as Usual (TAU)
29.0449
± 8.76967
Get Support From Friends and Family
Group
Value
95% CI
Comprehensive Trauma-Based Reentry Program
18.3846
± 7.46232
Treatment as Usual (TAU)
19.8764
± 7.20767
Sponsor's own description
The investigators are conducting a randomized controlled trial to assess the impact of Resiliency in Stressful Experiences (RISE) - a comprehensive trauma-based program for young men releasing from a southeastern state's prisons. The investigators are assessing whether treating trauma and providing other transitional supports - such as employment assistance - as young men return home will help to improve their community stability and enhance their psychological well-being, in turn, resulting in less likelihood that a person will become incarcerated in the future.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Florida State University
Last refreshed: 11 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04785677.